LUNG CONNECT is an international group of experts in the field of thoracic oncology and is an initiative of COR2ED. The group discusses the latest scientific and clinical insights, identifies educational needs, and develops educational programmes to support healthcare professionals globally to provide the best possible care to their patients.
LUNG CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from Bayer, Pierre Fabre Laboratories, Boehringer Ingelheim and AstraZeneca.
What’s new from LUNG CONNECT
Animated Video
The critical role of testing and management in NTRK-positive non-small cell lung cancer (NSCLC)
Using molecular testing to enable personalised care
Experts
Dr Herbert LoongEndorsed by
-
Downloadable
Resources -
5 MIN
-
Jun 2026 -
Conference update
Highlights from ASCO 2026
Expert insights on the latest data
Experts
Dr Herbert Loong, Dr Isabel Preeshagul, Prof. Mark Socinski, Prof. Evan Yu, Prof. Hans Prenen, Dr Paolo Tarantino-
Downloadable
Resources -
4 MIN
-
Jun 2026
-
The evolving TROP2-directed ADC landscape in metastatic NSCLC
Strategies to optimise the treatment experience
Experts
Prof. Nicolas Girard, Dr Louise Lim, Dr Jacob Sands, Mrs Stephanie McDonaldEndorsed by
-
Downloadable
Resources -
58 MIN
-
May 2026
-
Conference update
Oncogene-addicted NSCLC highlights from ELCC 2026
Expert insights on the latest NSCLC data
Experts
Prof. Nicolas GirardEndorsed by
-
Downloadable
Resources -
4 MIN
-
Mar 2026
-
Speed ReadInfographic / Flashcard
Select datopotamab deruxtecan-associated adverse events
Prophylaxis, monitoring, and management
Experts
Dr Aaron LisbergEndorsed by
-
Downloadable
Resources -
3 MIN
-
Mar 2026
-
Conference update
Highlights from ESMO 2025
Experts join us at ESMO 2025 to share their views on new data on GU, lung, breast, gynecological and upper GI cancers
Experts
Dr Herbert Loong, Prof. Viktor Grünwald, Prof. Thomas Powles, Dr Elisa Agostinetto, Prof. Nicoletta Colombo, Dr Elizabeth SmythEndorsed by
-
Downloadable
Resources -
6 MIN
-
Oct 2025
-
